Logo image of GENI

GENIUS SPORTS LTD (GENI) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:GENI - GG00BMF1JR16 - Common Stock

9.86 USD
-0.04 (-0.4%)
Last: 11/26/2025, 8:04:00 PM
9.85 USD
-0.01 (-0.1%)
After Hours: 11/26/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, GENI scores 4 out of 10 in our fundamental rating. GENI was compared to 132 industry peers in the Hotels, Restaurants & Leisure industry. While GENI has a great health rating, there are worries on its profitability. GENI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GENI has reported negative net income.
In the past year GENI had a positive cash flow from operations.
In the past 5 years GENI always reported negative net income.
In multiple years GENI reported negative operating cash flow during the last 5 years.
GENI Yearly Net Income VS EBIT VS OCF VS FCFGENI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

GENI has a Return On Assets of -11.36%. This is amonst the worse of the industry: GENI underperforms 82.58% of its industry peers.
With a Return On Equity value of -16.49%, GENI perfoms like the industry average, outperforming 43.18% of the companies in the same industry.
Industry RankSector Rank
ROA -11.36%
ROE -16.49%
ROIC N/A
ROA(3y)-14.16%
ROA(5y)-22.16%
ROE(3y)-19.14%
ROE(5y)-28.64%
ROIC(3y)N/A
ROIC(5y)N/A
GENI Yearly ROA, ROE, ROICGENI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

GENI has a worse Gross Margin (21.98%) than 84.09% of its industry peers.
GENI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GENI Yearly Profit, Operating, Gross MarginsGENI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

7

2. Health

2.1 Basic Checks

GENI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GENI has been increased compared to 1 year ago.
Compared to 1 year ago, GENI has an improved debt to assets ratio.
GENI Yearly Shares OutstandingGENI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M 200M
GENI Yearly Total Debt VS Total AssetsGENI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

GENI has an Altman-Z score of 3.41. This indicates that GENI is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.41, GENI belongs to the best of the industry, outperforming 80.30% of the companies in the same industry.
GENI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.41
ROIC/WACCN/A
WACC9.35%
GENI Yearly LT Debt VS Equity VS FCFGENI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

GENI has a Current Ratio of 1.73. This is a normal value and indicates that GENI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.73, GENI is in the better half of the industry, outperforming 79.55% of the companies in the same industry.
A Quick Ratio of 1.73 indicates that GENI should not have too much problems paying its short term obligations.
GENI has a better Quick ratio (1.73) than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.73
GENI Yearly Current Assets VS Current LiabilitesGENI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for GENI have decreased strongly by -74.07% in the last year.
Looking at the last year, GENI shows a very strong growth in Revenue. The Revenue has grown by 30.70%.
The Revenue has been growing by 24.82% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-74.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-320%
Revenue 1Y (TTM)30.7%
Revenue growth 3Y24.82%
Revenue growth 5YN/A
Sales Q2Q%38.34%

3.2 Future

The Earnings Per Share is expected to grow by 44.95% on average over the next years. This is a very strong growth
GENI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.81% yearly.
EPS Next Y30.31%
EPS Next 2Y56.84%
EPS Next 3Y44.95%
EPS Next 5YN/A
Revenue Next Year26%
Revenue Next 2Y21.49%
Revenue Next 3Y19.99%
Revenue Next 5Y17.81%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
GENI Yearly Revenue VS EstimatesGENI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
GENI Yearly EPS VS EstimatesGENI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GENI. In the last year negative earnings were reported.
GENI is valuated quite expensively with a Price/Forward Earnings ratio of 79.38.
Based on the Price/Forward Earnings ratio, GENI is valued a bit more expensive than 66.67% of the companies in the same industry.
GENI is valuated expensively when we compare the Price/Forward Earnings ratio to 36.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 79.38
GENI Price Earnings VS Forward Price EarningsGENI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

62.12% of the companies in the same industry are cheaper than GENI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 430.55
EV/EBITDA N/A
GENI Per share dataGENI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
GENI's earnings are expected to grow with 44.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.84%
EPS Next 3Y44.95%

More info and screens

0

5. Dividend

5.1 Amount

GENI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENIUS SPORTS LTD

NYSE:GENI (11/26/2025, 8:04:00 PM)

After market: 9.85 -0.01 (-0.1%)

9.86

-0.04 (-0.4%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)03-02 2026-03-02/amc
Inst Owners95.87%
Inst Owner Change-2.74%
Ins Owners8.59%
Ins Owner ChangeN/A
Market Cap2.50B
Revenue(TTM)604.52M
Net Income(TTM)-119.17M
Analysts83.2
Price Target15.33 (55.48%)
Short Float %10.26%
Short Ratio4.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1971.5%
Min EPS beat(2)-2756.23%
Max EPS beat(2)-1186.76%
EPS beat(4)1
Avg EPS beat(4)-1234.18%
Min EPS beat(4)-2756.23%
Max EPS beat(4)23.27%
EPS beat(8)2
Avg EPS beat(8)-582.96%
EPS beat(12)2
Avg EPS beat(12)-433.44%
EPS beat(16)4
Avg EPS beat(16)-321.25%
Revenue beat(2)1
Avg Revenue beat(2)1.03%
Min Revenue beat(2)-1.76%
Max Revenue beat(2)3.82%
Revenue beat(4)1
Avg Revenue beat(4)-0.48%
Min Revenue beat(4)-2.01%
Max Revenue beat(4)3.82%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)0.29%
Revenue beat(16)7
Avg Revenue beat(16)1.27%
PT rev (1m)0.18%
PT rev (3m)2.45%
EPS NQ rev (1m)-0.7%
EPS NQ rev (3m)17.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-43%
Revenue NQ rev (1m)0.97%
Revenue NQ rev (3m)1.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 79.38
P/S 4.13
P/FCF 430.55
P/OCF 29.7
P/B 3.46
P/tB 10.63
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)0.12
Fwd EY1.26%
FCF(TTM)0.02
FCFY0.23%
OCF(TTM)0.33
OCFY3.37%
SpS2.39
BVpS2.85
TBVpS0.93
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.36%
ROE -16.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.98%
FCFM 0.96%
ROA(3y)-14.16%
ROA(5y)-22.16%
ROE(3y)-19.14%
ROE(5y)-28.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 118.97%
Cap/Sales 12.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 1.73
Altman-Z 3.41
F-Score5
WACC9.35%
ROIC/WACCN/A
Cap/Depr(3y)73.83%
Cap/Depr(5y)N/A
Cap/Sales(3y)12.81%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-320%
EPS Next Y30.31%
EPS Next 2Y56.84%
EPS Next 3Y44.95%
EPS Next 5YN/A
Revenue 1Y (TTM)30.7%
Revenue growth 3Y24.82%
Revenue growth 5YN/A
Sales Q2Q%38.34%
Revenue Next Year26%
Revenue Next 2Y21.49%
Revenue Next 3Y19.99%
Revenue Next 5Y17.81%
EBIT growth 1Y-55.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year384.04%
EBIT Next 3Y88.5%
EBIT Next 5Y54.95%
FCF growth 1Y110.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1224.02%
OCF growth 3YN/A
OCF growth 5YN/A

GENIUS SPORTS LTD / GENI FAQ

What is the ChartMill fundamental rating of GENIUS SPORTS LTD (GENI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to GENI.


What is the valuation status of GENIUS SPORTS LTD (GENI) stock?

ChartMill assigns a valuation rating of 1 / 10 to GENIUS SPORTS LTD (GENI). This can be considered as Overvalued.


How profitable is GENIUS SPORTS LTD (GENI) stock?

GENIUS SPORTS LTD (GENI) has a profitability rating of 1 / 10.